Bionano Genomics, Inc. (BNGO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Bionano Genomics (NASDAQ:BNGO) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano ...

Bionano Genomics Inc (NASDAQ:BNGO) is set to release its Q1 2026 earnings on May 13, 2026. The consensus estimate for Q1 2026 revenue is $6.57 million, and the earnings are expected to come in at ...

Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Image source: The Motley Fool. Management attributed revenue softness to supply constraints in consumables, not demand weakness, and indicated expected recovery as manufacturing delays are resolved.

PM ETSAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, ...

In this era of personalized medicine, individualized gene mapping is key – which is why San Diego startup BioNano Genomics’ Irys System just attracted a robust infusion of cash. The company just ...

Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.75. Operator: Good day, and welcome to the Bionano’s Third Quarter 2023 Earnings Conference Call.

Bionano Genomics Inc BNGO shares continue to trade higher Wednesday after the company on Tuesday highlighted a study showing that optical genome mapping better detected structural variations in liver ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...